Sanjay Shukla, President and CEO at aTYR PHARMA INC (ATYR), sold 7,490 shares at $0.98 ($7K) on 2026-02-04, disclosed to the SEC on 2026-02-04.
Open-market sale of $7k ATYR by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.98 | 3,745 | $4K | 49.9% |
| 2 | $0.98 | 3,745 | $4K | 50.1% |
| Total | $0.98 avg | 7,490 | $7K | 100% |
| Filing → |
| LIFE | BUY | 2023-11-13 | $17K | — | Filing → |
| LIFE | BUY | 2023-08-01 | $30K | — | Filing → |
| LIFE | BUY | 2022-11-21 | $21K | — | Filing → |